Adult Cells Prompted to Become Patient-Specific Stem Cells
Previously, scientists identified four genes that can transform adult stem cells into induced pluripotent stem cells (iPSCs), which have the capacity to differentiate into specialized cells of the body. However, these genes are delivered by a retrovirus, becoming integrated into the DNA and may, over an extended period of time, activate cancer-causing genes. To overcome this issue, Justin K. Ichida, from Harvard Stem Cell Institute (Massachusetts, USA), and colleagues substituted small chemical molecules for two of the genes, successfully demonstrating an alternative for converting one type of cell into another. The team observes that: “By using a non-biased chemical screening approach, we uncovered a previously unknown way to make stem cells. This discovery is exciting because it demonstrates the feasibility of using chemicals to make safer patient-specific stem cells for transplantation medicine.” Previously, scientists identified four genes that can transform adult stem cells into induced pluripotent stem cells (iPSCs), which have the capacity to differentiate into specialized cells of the body. However, these genes are delivered by a retrovirus, becoming integrated into the DNA and may, over an extended period of time, activate cancer-causing genes. To overcome this issue, Justin K. Ichida, from Harvard Stem Cell Institute (Massachusetts, USA), and colleagues substituted small chemical molecules for two of the genes, successfully demonstrating an alternative for converting one type of cell into another. The team observes that: “By using a non-biased chemical screening approach, we uncovered a previously unknown way to make stem cells. This discovery is exciting because it demonstrates the feasibility of using chemicals to make safer patient-specific stem cells for transplantation medicine.”
Justin K. Ichida, Joel Blanchard, Kelvin Lam, Esther Y. Son, Julia E. Chung, Dieter Egli, Kyle M. Loh, Ava C. Carter, Francesco P. Di Giorgio, Kathryn Koszka, Danwei Huangfu, Hidenori Akutsu, David R. Liu, Lee L. Rubin, Kevin Eggan. “A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog.” Cell Stem Cell, 08 October 2009; doi:10.1016/j.stem.2009.09.012.
Health Headlines
upcoming Events
U.S. Events
congresses
workshop
-
Bio-Identical Hormone Replacement Therapy Workshop
| Los Angeles, CA
May 14-16, 2010
fellowships
-
FELLOWSHIP IN ANTI-AGING & REGENERATIVE MEDICINE,
Modules II & V | Boca Raton, FL
MAR. 19-21, 2010 -
FELLOWSHIP IN ANTI-AGING & REGENERATIVE MEDICINE,
Modules I, VII & X | Orlando, FL
APR. 15-17, 2010 -
FELLOWSHIP IN AESTHETIC MEDICINE, Module II
Orlando, FL | APR. 14-15, 2010 -
FELLOWSHIP IN PREVENTATIVE MEDICINE, NUTRITION & SPORTS MEDICINE Module I
Orlando, FL | APR. 14-16, 2010 -
FELLOWSHIP IN PREVENTATIVE MEDICINE, NUTRITION & SPORTS MEDICINE, Module IV
Orlando, FL APR. 16-17, 2010 -
FELLOWSHIP IN ANTI-AGING & REGENERATIVE MEDICINE,
Modules IV & V | Los Angeles, CA
May 14-16, 2010 -
FELLOWSHIP IN INTEGRATIVE CANCER THERAPIES, Module V
Boca Raton, FL | MAY 20-21, 2010 -
FELLOWSHIP IN INTEGRATIVE CANCER THERAPIES, Module VI
Boca Raton, FL | MAY 22-23, 2010 -
FELLOWSHIP IN ANTI-AGING & REGENERATIVE MEDICINE,
Modules III & XI | Boca Raton, FL
JUNE 25-27, 2010
symposiums
- CARIBBEAN MEDICAL CONGRESS
San Juan, PR | Sept. 1-5, 2010 -
Advanced Hormone Symposium
Chicago, IL | Oct. 8-10, 2010
International Events
- Milan | Mar. 18-20, 2010
- Kuala Lumpur | Apr. 29 - May 2, 2010
- Bangkok | May 27 - May 29, 2010
- Bucharest | May 2010 (pending)
- Seoul | May 2010 (pending)
- Melbourne | Aug. 21-22, 2010
- Bali | Oct. 8-10, 2010
- Dubai | Oct. 26-27, 2010
- Jakarta | October 2010 (pending)
- Sao Paulo | Nov. 5-6, 2010
- Shanghai | November 2010 (pending)
- Germany | Date pending
- Mexico City | Jan/Feb 2011 (pending)


